DK124091D0 - Farmaceutisk genprodukt - Google Patents

Farmaceutisk genprodukt

Info

Publication number
DK124091D0
DK124091D0 DK911240A DK124091A DK124091D0 DK 124091 D0 DK124091 D0 DK 124091D0 DK 911240 A DK911240 A DK 911240A DK 124091 A DK124091 A DK 124091A DK 124091 D0 DK124091 D0 DK 124091D0
Authority
DK
Denmark
Prior art keywords
reproduct
pharmaceutical
gels
poise
wounds
Prior art date
Application number
DK911240A
Other languages
English (en)
Other versions
DK124091A (da
Inventor
Larry Bogart
Raymond R Burns
Margaret M Felice
Wallace H Pippin
Original Assignee
Scott Paper Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scott Paper Co filed Critical Scott Paper Co
Publication of DK124091D0 publication Critical patent/DK124091D0/da
Publication of DK124091A publication Critical patent/DK124091A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/009—Materials resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0014—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
DK124091A 1989-10-27 1991-06-25 Farmaceutisk genprodukt DK124091A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/428,156 US5271943A (en) 1989-10-27 1989-10-27 Wound gel compositions containing sodium chloride and method of using them
PCT/US1990/005681 WO1991006323A1 (en) 1989-10-27 1990-10-12 Wound gel compositions and methods of using them

Publications (2)

Publication Number Publication Date
DK124091D0 true DK124091D0 (da) 1991-06-25
DK124091A DK124091A (da) 1991-08-20

Family

ID=23697769

Family Applications (1)

Application Number Title Priority Date Filing Date
DK124091A DK124091A (da) 1989-10-27 1991-06-25 Farmaceutisk genprodukt

Country Status (13)

Country Link
US (1) US5271943A (da)
EP (1) EP0452470B1 (da)
JP (1) JP2617260B2 (da)
KR (1) KR920700705A (da)
AT (1) ATE163863T1 (da)
AU (1) AU636686B2 (da)
CA (1) CA2042609C (da)
DE (1) DE69032125T2 (da)
DK (1) DK124091A (da)
IE (1) IE903638A1 (da)
MY (1) MY107267A (da)
PT (1) PT95695A (da)
WO (1) WO1991006323A1 (da)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2119758C1 (ru) * 1991-11-16 1998-10-10 СПС Интернэшнл Инк. Способ получения целлюлозосодержащего зернового экстракта
GB2261671B (en) * 1991-11-16 1996-07-03 Gb Biotech Gel production from plant matter
US6033712A (en) * 1994-05-13 2000-03-07 Ei Du Pont De Nemours And Company Gel production from plant matter
US5786470A (en) * 1991-11-16 1998-07-28 Dalgety Food Ingredients Limited Gel production from plant matter
US7060287B1 (en) * 1992-02-11 2006-06-13 Bioform Inc. Tissue augmentation material and method
US7968110B2 (en) * 1992-02-11 2011-06-28 Merz Aesthetics, Inc. Tissue augmentation material and method
US5552162A (en) * 1993-02-09 1996-09-03 Arch Development Corporation Method for improvement of scar size and appearance
US5399358A (en) * 1993-11-12 1995-03-21 Edward Mendell Co., Inc. Sustained release formulations for 24 hour release of metroprolol
US5670169A (en) * 1993-12-20 1997-09-23 E.R. Squibb & Sons, Inc. Wound hydrating gel with novel preservative system and low cytotoxicity
US5503825A (en) * 1994-01-10 1996-04-02 Lane; Barry Lip balm composition
US5762955A (en) 1994-02-04 1998-06-09 Smith; Stephen Jay Method for application and maintenance of medication on body tissue
US6780425B1 (en) * 1994-02-04 2004-08-24 Stephen J. Smith Method for application and maintenance of medication on body tissue
US5399359A (en) * 1994-03-04 1995-03-21 Edward Mendell Co., Inc. Controlled release oxybutynin formulations
AU687840B2 (en) * 1994-03-15 1998-03-05 Dorothy E. Stofer Topical composition for burn relief and method of use
US5399362A (en) * 1994-04-25 1995-03-21 Edward Mendell Co., Inc. Once-a-day metoprolol oral dosage form
US5814031A (en) * 1995-03-02 1998-09-29 Mooney; Mark Structured occllusive dressings
US5654013A (en) * 1995-03-13 1997-08-05 Taylor; Lesli A. Method for treating rosacea
WO1997003710A1 (en) * 1995-07-19 1997-02-06 Innovative Technologies Limited Wound treatment composition
US5733884A (en) 1995-11-07 1998-03-31 Nestec Ltd. Enteral formulation designed for optimized wound healing
WO1997026865A1 (en) * 1996-01-29 1997-07-31 Edward Mendell Co., Inc. Sustained release excipient
US6309661B1 (en) 1996-02-28 2001-10-30 Carla A. Haynes Solid polysaccharide materials for use as wound dressings
US5587156A (en) * 1996-04-18 1996-12-24 Critical Dimension, Incorporated Shaving compositions containing particulate additives
US6800278B1 (en) 1996-10-28 2004-10-05 Ballard Medical Products, Inc. Inherently antimicrobial quaternary amine hydrogel wound dressings
US5849281A (en) * 1996-11-12 1998-12-15 S. C. Johnson & Son, Inc. Method of soap-free shaving
IL141688A0 (en) * 1998-09-04 2002-03-10 Scios Inc Hydrogel compositions for the controlled release administration of growth factors
US6469066B1 (en) * 1998-12-18 2002-10-22 Palladin Healthcare International, Ltd. Composition for pain mediation and apparatus and method of use thereof
US6333054B1 (en) 1999-10-21 2001-12-25 Amuchina S.P.A. Topical, non-cytotoxic, antimicrobial hydrogel with thixotropic properties
US6337076B1 (en) * 1999-11-17 2002-01-08 Sg Licensing Corporation Method and composition for the treatment of scars
JP2001139477A (ja) * 1999-11-17 2001-05-22 Coherent Technology:Kk 創傷部位の組織細胞増殖促進液
US20060122082A1 (en) * 2000-02-17 2006-06-08 Leonard Paul Foam/spray producing compositions and dispensing system therefor
US6977323B1 (en) 2000-02-17 2005-12-20 3M Innovative Properties Company Foam-on-film medical articles
US6548727B1 (en) 2000-02-17 2003-04-15 3M Innovative Properties Company Foam/film composite medical articles
US20030104386A1 (en) * 2001-08-31 2003-06-05 The Regents Of The University Of California Methods for the specific detection of redox-active tags and the use thereof for capillary gel electrophoresis and DNA sequencing
JP5140218B2 (ja) 2001-09-14 2013-02-06 有限会社コヒーレントテクノロジー 表面洗浄・表面処理に適した帯電アノード水の製造用電解槽及びその製造法、並びに使用方法
WO2003048421A1 (en) 2001-12-05 2003-06-12 Micromed Laboratories, Inc. Method and apparatus for producing negative and positive oxidative reductive potential (orp) water
AU2003230805A1 (en) * 2002-04-05 2003-10-27 Penwest Pharmaceuticals Co. Sustained release metoprolol formulations
ATE367165T1 (de) * 2002-04-30 2007-08-15 Sifi Spa Xanthangummi enthaltende reepithelialisierende pharmazeutische zubereitungen
WO2004024197A1 (en) * 2002-09-11 2004-03-25 Johnson & Johnson Medical Limited Wound dressing materials comprising complexes of anionic polysaccharides with silver
WO2004024187A2 (en) * 2002-09-13 2004-03-25 Zicam, Llc. Compositions to reduce congestion and methods for application thereof to the nasal membrane
WO2004069032A2 (en) * 2003-01-29 2004-08-19 Sandhill Scientific, Inc. Viscous swallow medium and method of use for esophageal function testing
IL156374A0 (en) * 2003-06-10 2004-01-04 Danenberg Holdings 2000 Ltd N Method for removing a pigmented section of skin
IL157696A0 (en) * 2003-09-01 2004-03-28 Hawk Medical Technologies Ltd Apparatus and method for removing a pigmented section of skin
US9168318B2 (en) * 2003-12-30 2015-10-27 Oculus Innovative Sciences, Inc. Oxidative reductive potential water solution and methods of using the same
KR20050086324A (ko) * 2004-02-25 2005-08-30 김아란 3%부터 9%까지 셀라인 (염수)
US11167058B2 (en) 2005-02-15 2021-11-09 Virginia Commonwealth University Hemostasis of wound having high pressure blood flow
EP1863502B1 (en) 2005-03-23 2018-09-12 Sonoma Pharmaceuticals, Inc. Method of treating skin ulcers using oxidative reductive potential water solution
BRPI0610901B1 (pt) 2005-05-02 2019-04-16 Oculus Innovative Sciences, Inc. Uso de uma solução aquosa de potencial oxi-redutivo (orp).
CN101232858B (zh) * 2005-08-01 2011-08-24 华克医药科技有限公司 根除色素沉着和疤痕组织的方法和装置
US20070048249A1 (en) 2005-08-24 2007-03-01 Purdue Research Foundation Hydrophilized bactericidal polymers
JP2009514597A (ja) 2005-11-04 2009-04-09 ライフサイエンス・プラス・インコーポレイテッド 生体吸収性止血ガーゼ
JP5449780B2 (ja) * 2006-01-20 2014-03-19 オキュラス イノヴェイティヴ サイエンシズ、インコーポレイテッド 酸化還元電位水溶液を用いた炎症及び過敏症の治療又は予防方法
US20070184087A1 (en) 2006-02-06 2007-08-09 Bioform Medical, Inc. Polysaccharide compositions for use in tissue augmentation
US7604819B2 (en) 2006-05-26 2009-10-20 Z-Medica Corporation Clay-based hemostatic agents and devices for the delivery thereof
US9463119B2 (en) * 2007-01-18 2016-10-11 Abigo Medical Ab Wound dressing with a bacterial adsorbing composition and moisture holding system
PT103765A (pt) * 2007-06-20 2008-12-22 Inst Superior Tecnico Síntese e aplicação de uma família de novos materiais resultantes do cruzamento entre gelatina e sais orgânicos
US20110189309A1 (en) * 2007-07-12 2011-08-04 Whipbird Pain Relief Pty Ltd Acn 132 827 411 Topical medicament
FR2921071A1 (fr) * 2007-09-14 2009-03-20 Jean Francois Regis Moreel Procede de prelevement et de detection et/ou d'identification de microorganismes presents dans un echantillon
US20120164087A1 (en) * 2009-04-24 2012-06-28 Carter Daniel C Human Serum Albumin-Based Topical Ointment for Treatment of Acne, Psoriasis, Egfr-Induced Toxicity, Premature Skin Aging and Other Skin Conditions
BRPI1011886B1 (pt) 2009-06-15 2022-05-03 Invekra, S.A.P.I De C.V Solução antimicrobiana de baixo ph
US9119605B2 (en) 2010-05-06 2015-09-01 Zimmer, Inc. Synthetic polymer adhesives and methods for making, using and delivering the same
US20210052767A1 (en) * 2012-04-23 2021-02-25 Foshan United Medical Technologies Ltd. Antimicrobial fiber comprising silver, fabric and wound dressing comprising the antimicrobial fiber, and methods for manufacturing the fiber, the fabric, and the wound dressing
CN103170004B (zh) * 2012-04-23 2016-08-31 佛山市优特医疗科技有限公司 一种制备含银纤维伤口敷料的方法
BR112014031439A8 (pt) 2012-06-22 2023-01-31 Z Medica Llc Dispositivos e curativos hemostáticos e para feridas e processos para produzir dispositivo hemostático e para tratar feridas
WO2015075406A1 (en) * 2013-11-19 2015-05-28 Lipopeptide Ab New treatment of chronic ulcers
CA3012299C (en) 2016-01-31 2022-05-31 Mediwound Ltd. Debriding composition for treating wounds
CA3021485C (en) 2016-04-18 2022-02-01 Evgenia LOZINSKY Methods of debridement of chronic wounds
CN110612076A (zh) * 2016-12-22 2019-12-24 应用纸巾技术有限公司 用于伤口处理的装置和方法
US20180340046A1 (en) 2017-05-27 2018-11-29 Poly Group LLC Dispersible antimicrobial complex and coatings therefrom
US20180362678A1 (en) 2017-06-16 2018-12-20 Poly Group LLC Polymeric antimicrobial surfactant
US11141458B2 (en) * 2019-07-17 2021-10-12 Mycomagic Biotechnology Co., Ltd. Composition and methods for promoting and treating chronic wound healing
US20210186873A1 (en) * 2019-12-19 2021-06-24 Zaki Yusuf Gel compositions for mitigation of burn injuries, kits containing the gel compositions, and associated methods

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4192727A (en) * 1976-08-24 1980-03-11 Union Carbide Corporation Polyelectrolyte hydrogels and methods of their preparation
US4125478A (en) * 1976-11-26 1978-11-14 The Dow Chemical Company Air treating gel employing amide polymer gelling agent
US4265233A (en) * 1978-04-12 1981-05-05 Unitika Ltd. Material for wound healing
US4369124A (en) * 1979-09-14 1983-01-18 Halliburton Company High viscosity complexed aqueous gels and methods and additives for forming such gels
US4318746A (en) * 1980-01-08 1982-03-09 Ipco Corporation Highly stable gel, its use and manufacture
US4393048A (en) 1980-02-15 1983-07-12 The United States Of America As Represented By The Secretary Of The Army Protective gel composition for wounds
US4299825A (en) * 1980-07-03 1981-11-10 Celanese Corporation Concentrated xanthan gum solutions
DK260782A (da) 1981-06-12 1982-12-13 Nat Res Dev Hydrogeler
JPS58206751A (ja) 1982-05-26 1983-12-02 日石三菱株式会社 創傷被覆材
DE3376957D1 (en) 1982-06-24 1988-07-14 Robert Alan Smith Pharmaceutical gel composition
US4540568A (en) * 1982-10-14 1985-09-10 Trager Seymour F Injectionable viscoelastic ophthalmic gel
US4732755A (en) 1983-01-17 1988-03-22 University Of Health Sciences/The Chicago Medical School Skin burn treatment
AU4198785A (en) * 1984-05-07 1985-11-14 Lloyd A. Ferreira Conductive material and biomedical electrode
US4671267A (en) 1984-05-30 1987-06-09 Edward I. Stout Gel-based therapy member and method
US4587284A (en) 1985-06-14 1986-05-06 Ed. Geistlich Sohne Ag Fur Chemische Industrie Absorbent polymer material and its preparation
US4692328A (en) * 1985-09-24 1987-09-08 Dynatech Corporation Biologically useful polymer preparations
US4800815A (en) * 1987-03-05 1989-01-31 Halliburton Company Shaped charge carrier
FR2620866B1 (fr) * 1987-09-18 1989-12-01 Rhone Poulenc Chimie Procede de preparation de materiaux supraconducteurs et materiaux ainsi obtenus
NZ226171A (en) 1987-09-18 1990-06-26 Ethicon Inc Gel formulation containing polypeptide growth factor
US4944948A (en) * 1989-02-24 1990-07-31 Liposome Technology, Inc. EGF/Liposome gel composition and method

Also Published As

Publication number Publication date
AU6743490A (en) 1991-05-31
AU636686B2 (en) 1993-05-06
DK124091A (da) 1991-08-20
IE903638A1 (en) 1991-05-08
DE69032125D1 (de) 1998-04-16
CA2042609C (en) 2001-10-02
MY107267A (en) 1995-10-31
ATE163863T1 (de) 1998-03-15
WO1991006323A1 (en) 1991-05-16
CA2042609A1 (en) 1991-04-28
EP0452470A1 (en) 1991-10-23
DE69032125T2 (de) 1998-07-02
EP0452470B1 (en) 1998-03-11
US5271943A (en) 1993-12-21
KR920700705A (ko) 1992-08-10
PT95695A (pt) 1991-09-13
JPH04502569A (ja) 1992-05-14
JP2617260B2 (ja) 1997-06-04

Similar Documents

Publication Publication Date Title
DK124091A (da) Farmaceutisk genprodukt
BR8107560A (pt) Estimulacao ultra-sonica da consolidacao de fraturas osseas
IT8224839A0 (it) Polimeri reattivi per la cura di affezioni cutanee.
NO900227L (no) Ekstruderbar elastisk gel for anvendelse som baerer for terapeutisk middel.
DK152287A (da) Farmaceutisk vaginalmiddel
BE780356A (fr) Element chirurgical de connexion pour la reduction de fracturesd'os
ATA91797A (de) Eine das vwf-propeptid enthaltende pharmazeutische präparation
BG94738A (bg) Използване на разтвор на йод за лечение на заболявания, свързани с йодна недостатъчност
IT9041503A0 (it) Dispositivo per la cura chirurgica dell'ametropia
PT89786A (pt) Penso cirurgico de pressao
ES2081279T3 (es) Utilizacion de 15-desoxiespergualina como medicamento.
DE68905076D1 (de) Pharmazeutische zusammensetzung fuer die behandlung von hautwunden.
ATE75938T1 (de) Enantiomere des propafenons enthaltende therapeutische mittel.
IT8622451A0 (it) Protesi ortopedica per la riduzione di fratture ossee, materiale per la sua fabbricazione e procedimenti per ottenerli.
DE3668338D1 (de) Kontinuierliche behandlung von spannungslosem gewebe.
NO912521L (no) Saargelblandinger og fremgangsmaater for anvendelse av disse
DK210187D0 (da) Medicinsk tampon
IT1213568B (it) Derivati imidazolici adattivita' terapeutica, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
JO1493B1 (en) Pharmaceutical combination for treating high blood pressure
NO912254L (no) Terapeutiske dekapeptider.
FI890595A0 (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara tiadiazoler.
DK681288A (da) Aenootropt terapeutisk laegemiddelae
IT1102304B (it) Composizione farmaceutica per la cura della sordita' e del ronzio auricolare
DE59108793D1 (de) Orthopädischer Mass- und Therapieschuhe
ATE70971T1 (de) Foerderung der heilung von meniskusgewebe.